Martin Yarmush is one of the leading investigators in molecular and cellular bioengineering, with seminal contributions to the fields of hepatic and skin tissue engineering, applied immunology, metabolic engineering, and genomics and proteomics. As director of the
Center for Engineering in Medicine at the Massachusetts General Hospital, he pursues several research topics:
-
BioMEMS: Dynamic cell and tissue microsystems, microscale cellular bioreactors
-
Metabolic Engineering: Organ and cell cefatting, stem cell modulation via metabolic means
-
Molecular and Nanosystems Bioengineering: Nanoparticles for drug delivery and cancer diagnostics; improved viral vectors for gene therapy; new viral infection treatments
-
Neuroengineering: Brain and spinal cord-on-a-chip, Fragile-X Syndrome
-
Stem Cell Bioengineering: Differentiation to hepatocytes, pancreatic cells and neural cells
-
Tissue Engineering: Bioartificial Liver and Skin, Tissue Models of Macular Degeneration
-
Transplantation: New Techniques for Reconditioning Organs